Early Bortezomib Therapy for Refractory Anti-NMDA Receptor Encephalitis

Introduction: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an increasingly recognized form of immune-mediated encephalitis. Here we present a case that represents the shortest hospitalization-to-bortezomib treatment timeline (42 days), and we believe that this is reflected in the patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Turnbull, Marion T., Siegel, Jason L., Becker, Tara L., Stephens, Alana J., Lopez-Chiriboga, A. Sebastian, Freeman, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118211/
https://www.ncbi.nlm.nih.gov/pubmed/32292386
http://dx.doi.org/10.3389/fneur.2020.00188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118211/
https://www.ncbi.nlm.nih.gov/pubmed/32292386
http://dx.doi.org/10.3389/fneur.2020.00188

Ejemplares similares